HUMAN MONOCLONAL-ANTIBODY PRODUCTION - CURRENT STATUS AND FUTURE-PROSPECTS

[1] ABRAMS PG, 1984, J IMMUNOL, V132, P1611

[2] ABRAMS PG, 1983, J IMMUNOL, V131, P1201

[3] THE PRODUCTION OF MORE USEFUL MONOCLONAL-ANTIBODIES .2. THE USE OF SOMATIC-CELL GENETIC AND RECOMBINANT-DNA TECHNOLOGY TO TAILOR-MAKE MONOCLONAL-ANTIBODIES [J]. IMMUNOLOGY TODAY, 1986, 7 (12): : 380 - 383

[4] CONTINUOUS HYBRIDOMA GROWTH AND MONOCLONAL-ANTIBODY PRODUCTION IN HOLLOW FIBER REACTORS SEPARATORS [J]. BIOTECHNOLOGY AND BIOENGINEERING, 1986, 28 (05) : 646 - 658

[5] EPSTEIN-BARR VIRUS SUSCEPTIBILITY OF NORMAL HUMAN B-LYMPHOCYTE POPULATIONS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) : 208 - 220

[6] ANDREASEN RB, 1986, J IMMUNOL, V137, P1083

[7] ANDREASEN RB, 1987, IMMUNOLOGY SERIES, V13, P183

[8] ASTALDI GCB, 1982, J IMMUNOL, V128, P2539

[9] HUMAN MONOCLONAL-ANTIBODIES AGAINST MYCOBACTERIUM-LEPRAE [J]. INFECTION AND IMMUNITY, 1985, 49 (01) : 104 - 110

[10] BIEBER M, 1987, IMMUNOLOGY SERIES, V13, P39

[1] ABRAMS PG, 1984, J IMMUNOL, V132, P1611

[2] ABRAMS PG, 1983, J IMMUNOL, V131, P1201

[3] THE PRODUCTION OF MORE USEFUL MONOCLONAL-ANTIBODIES .2. THE USE OF SOMATIC-CELL GENETIC AND RECOMBINANT-DNA TECHNOLOGY TO TAILOR-MAKE MONOCLONAL-ANTIBODIES [J]. IMMUNOLOGY TODAY, 1986, 7 (12): : 380 - 383

[4] CONTINUOUS HYBRIDOMA GROWTH AND MONOCLONAL-ANTIBODY PRODUCTION IN HOLLOW FIBER REACTORS SEPARATORS [J]. BIOTECHNOLOGY AND BIOENGINEERING, 1986, 28 (05) : 646 - 658

[5] EPSTEIN-BARR VIRUS SUSCEPTIBILITY OF NORMAL HUMAN B-LYMPHOCYTE POPULATIONS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) : 208 - 220

[6] ANDREASEN RB, 1986, J IMMUNOL, V137, P1083

[7] ANDREASEN RB, 1987, IMMUNOLOGY SERIES, V13, P183

[8] ASTALDI GCB, 1982, J IMMUNOL, V128, P2539

[9] HUMAN MONOCLONAL-ANTIBODIES AGAINST MYCOBACTERIUM-LEPRAE [J]. INFECTION AND IMMUNITY, 1985, 49 (01) : 104 - 110

[10] BIEBER M, 1987, IMMUNOLOGY SERIES, V13, P39